Insider Transactions in Q3 2025 at Rocket Pharmaceuticals, Inc. (RCKT)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2025
|
John Militello |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+29.43%
|
-
|
|
Sep 08
2025
|
Jonathan David Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+20.96%
|
-
|
|
Sep 08
2025
|
Martin Wilson General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+34.45%
|
-
|
|
Aug 27
2025
|
Elisabeth Bjork |
BUY
Open market or private purchase
|
Direct |
10,000
+20.0%
|
$30,000
$3.41 P/Share
|
|
Aug 19
2025
|
Martin Wilson General Counsel |
SELL
Open market or private sale
|
Direct |
588
-0.43%
|
$1,764
$3.0 P/Share
|
|
Aug 19
2025
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct |
805
-0.36%
|
$2,415
$3.0 P/Share
|
|
Aug 19
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
361
-0.64%
|
$1,083
$3.0 P/Share
|
|
Aug 18
2025
|
Gaurav Shah CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,234
-0.28%
|
$6,702
$3.05 P/Share
|
|
Aug 18
2025
|
Martin Wilson General Counsel |
SELL
Open market or private sale
|
Direct |
1,004
-0.73%
|
$3,012
$3.06 P/Share
|
|
Aug 18
2025
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct |
1,680
-0.75%
|
$5,040
$3.06 P/Share
|
|
Aug 18
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
699
-1.23%
|
$2,097
$3.06 P/Share
|
|
Aug 14
2025
|
Martin Wilson General Counsel |
SELL
Open market or private sale
|
Direct |
12,109
-8.12%
|
$36,327
$3.02 P/Share
|
|
Aug 14
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
7,043
-11.0%
|
$21,129
$3.02 P/Share
|
|
Aug 14
2025
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct |
11,161
-4.74%
|
$33,483
$3.02 P/Share
|
|
Aug 04
2025
|
Christopher James Stevens Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
407,166
+50.0%
|
-
|
|
Jul 03
2025
|
Aaron Ondrey Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,477
-1.14%
|
$2,954
$2.88 P/Share
|